Capital Management Associates Pfizer Inc Transaction History

Capital Management Associates

$81.6 Million
Q2 2024

A detailed history of Capital Management Associates transactions in Pfizer Inc stock. As of the latest transaction made, Capital Management Associates holds 450 shares of PFE stock, worth $13,387. This represents 0.01% of its overall portfolio holdings.

Number of Shares

450

Previous 450 -0.0%

Holding current value

$13,387

Previous $12,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $20,904 - $27,152	-800 Reduced 64.0%	450 $12,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $17,698 - $20,477	-490 Reduced 28.16%	1,250 $45,000
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $14,731 - $19,178	-374 Reduced 17.69%	1,740 $70,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1.13 Million - $1.47 Million	-26,997 Reduced 92.74%	2,114 $108,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $10,283 - $12,553	-235 Reduced 0.8%	29,111 $1.27 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $298,071 - $353,419	-6,406 Reduced 17.92%	29,346 $1.54 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $995,748 - $1.23 Million	21,765 Added 155.61%	35,752 $1.85 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $17,767 - $26,337	430 Added 3.17%	13,987 $826,000
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $28,727 - $32,544	-800 Reduced 5.57%	13,557 $531,000
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $25,117 - $28,327	-750 Reduced 4.96%	14,357 $520,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $16,735 - $21,280	-500 Reduced 3.2%	15,107 $556,000
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $22,225 - $26,075	-700 Reduced 4.29%	15,607 $573,000
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $153,612 - $186,354	-5,100 Reduced 23.82%	16,307 $533,000
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $103,389 - $147,721	3,825 Added 21.76%	21,407 $699,000
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $40,030 - $45,429	-1,216 Reduced 6.47%	17,582 $689,000
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $120,700 - $156,512	3,715 Added 24.63%	18,798 $675,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $48,073 - $53,976	-1,300 Reduced 7.94%	15,083 $653,000
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $3,750 - $4,120	100 Added 0.61%	16,383 $696,000
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $53,858 - $61,404	-1,400 Reduced 7.92%	16,283 $711,000
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $6,894 - $8,362	200 Added 1.14%	17,683 $779,000
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $35,101 - $40,722	-1,100 Reduced 5.92%	17,483 $620,000
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $576,073 - $634,609	18,583	18,583 $663,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Associates , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Associates with notifications on news.

Account

Capital Management Associates Pfizer Inc Transaction History